Arbor Review: What Its Compounded GLP-1 Program Documents—and What It Does Not

A medication study and a telehealth subscription answer different questions. Research can establish outcomes for a particular drug product under defined conditions; a company’s documentation can explain who reviews an application, how prescriptions reach a pharmacy and what happens to a payment after cancellation. Arbor’s appeal rests on both kinds of information, but they should not be blended. Its public pages describe a comparatively inexpensive compounded injectable program with clinical oversight and nutrition support. They do not establish that Arbor’s patients achieve the results measured in trials of approved medicines.

This review examines Arbor’s public documentation consulted October 19, 2026, alongside FDA and NIH guidance and original clinical research. The current homepage and product pages agree on starting prices of $99 per month for semaglutide and $149 for tirzepatide. More consequential uncertainties remain around the dispensing pharmacy, the relationship between monthly refills and quarterly shipments, and whether dietitian services are included or optional. The strongest reading is neither blanket reassurance nor blanket dismissal: Arbor documents a real service structure, but several important claims need narrower interpretation.

At a glance

Advertised treatment and price: Compounded weekly injectable semaglutide starts at $99/month; compounded weekly injectable tirzepatide starts at $149/month. The minimum-price plan conditions are not fully established.
Sources: [8] [11] [5]
Who provides care: Harbor Health Inc. d/b/a Arbor operates the platform. Arbor identifies MD Integrations as its partner medical group and says independent providers deliver medical care.
Sources: [10] [8]
Product evidence boundary: The advertised compounded preparations are not FDA approved. Trials of approved products do not establish outcomes for Arbor or its compounded preparations.
Sources: [8] [1] [3] [4]
Payment options: Arbor offers monthly billing or optional prepaid three-, six- or twelve-month terms. It is cash-pay and does not accept insurance, Medicare, Medicaid or other government healthcare programs.
Sources: [10]
Cancellation versus refund: Cancellation stops future renewals, but payments generally become nonrefundable once a prescription is written; the first prescription makes an entire prepaid term nonrefundable.
Sources: [10] [6]

Start with the product, not the platform’s approval language

Arbor’s catalog advertises weekly injectable compounded semaglutide and compounded tirzepatide, identifying them as GLP-1 and GLP-1/GIP programs, respectively. Yet its FAQ also describes the platform as providing FDA-approved GLP-1 medications. That broader wording does not establish that the advertised compounded products are approved, or confirm current access to a particular branded product. The footer is more precise: clinicians may prescribe approved or compounded medications based on patient needs, and compounded medications are not reviewed by FDA for safety or effectiveness. Approval attaches to a specific drug product—not to Arbor, its clinicians or a pharmacy network.

FDA states that compounded preparations do not undergo its premarket review for safety, effectiveness and quality. That distinction is important, but nonapproval alone does not prove clinical inequivalence. FDA recommends compounded drugs for patients whose medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Arbor’s documentation does not establish how that individual-need assessment is recorded. Our guide to approved medicines and compounded preparations explains why product identity, formulation and regulatory status require separate questions rather than a single approval label.

How to interpret Arbor’s documented claims
Documented statement	What it supports	What remains unestablished
Compounded weekly injectable programs	The advertised route and product category	Equivalence to a specific approved product
Starting prices of $99 and $149/month	Current advertised entry prices	Which checkout selections qualify
Independent clinical review	A prescription decision is part of enrollment	A guaranteed prescription or individual outcome
Pharmacy-network fulfillment	A separate pharmacy fills prescriptions	The named dispensing pharmacy and its verification
Dietitian-led support	Nutrition support is advertised	Its precise cost, duration and included scope

Sources: [9] [8] [12] [1]

Research supports narrower conclusions than a program promise

The original STEP 1 and SURMOUNT-1 studies are relevant background for semaglutide and tirzepatide, but neither evaluated Arbor. STEP 1 studied subcutaneous semaglutide in adults with obesity, or overweight plus a weight-related condition, without diabetes, over 68 weeks, with lifestyle intervention in both groups. SURMOUNT-1 studied subcutaneous tirzepatide in a similar broad weight-management population without diabetes over 72 weeks. Both were randomized trials; neither tested Arbor’s dispensing arrangements, compounded formulations, clinical workflow or nutrition aftercare. Their findings therefore cannot serve as a measured success rate for this subscription.

Tolerability and study sponsorship also belong in the evidence picture: gastrointestinal effects contributed to discontinuation in these trials, which were funded by Novo Nordisk and Eli Lilly, respectively. Reading the studies does not establish an individual’s likely result or justify ranking providers by drug-trial averages. Our explanations of what STEP 1 actually measured and how to read SURMOUNT-1 separate study populations and methods from commercial claims. For Arbor specifically, the consulted documentation does not provide independently evaluated patient outcomes that bridge this gap.

Sources: [3] [4]

The company, medical group and pharmacy have different jobs

The terms identify the operator as Harbor Health Inc. d/b/a Arbor, a Delaware corporation with a published principal address in Dover. They explicitly say Arbor is a technology platform, not the entity providing medical advice, diagnosis or treatment. Separate professional entities employ or contract with the licensed clinicians, and the website identifies MD Integrations as the partner medical group. Arbor says its physicians are board-certified and licensed where they prescribe, with training in fields including obesity medicine, family medicine or metabolic health. Those are provider statements, not credentials independently verified for this review.

Arbor also says it is not a pharmacy and does not dispense medications. Prescriptions may be routed to independent network pharmacies. The tirzepatide page describes compounding by licensed U.S. 503A and 503B pharmacies, while the FAQ says compounded prescriptions are written for a specific 503A pharmacy and cannot transfer to CVS or Walgreens. The consulted pages do not name the dispensing pharmacies or provide independently checked licensing, purity or potency documentation. Before paying, a useful request is the actual pharmacy’s name, contact details and prescribed product description—not simply reassurance that the platform has pharmacy partners.

Sources: [10] [8] [12] [5]

Enrollment is a clinical decision, not automatic approval

Arbor restricts access to adults 18 or older located in the United States. Its terms do not promise service in every state; the FAQ says intake checks the shipping state and clinician licensure before approval. The questionnaire collects height, weight, medical history, current medications, allergies and weight-loss goals. Enrollment involves an online assessment and checkout, followed by clinical review. Some applicants may need a live audio or video consultation depending on state requirements and clinical need. Although same-day approval appears in marketing, the FAQ describes 24–48 hours as the usual review period and allows requests for additional information.

The semaglutide page describes typical applicants as adults with BMI of 27 or higher, subject to medical review; this is Arbor’s description, not a universal eligibility rule. Its published exclusions include pregnancy, breastfeeding, planned pregnancy, age under 18, personal or family history of medullary thyroid carcinoma, MEN-2, active pancreatitis, severe gastrointestinal disease and other specified contraindications. A clinician may approve, suggest an alternative or decline treatment. NIH guidance emphasizes that medication decisions also involve health conditions, other medicines, side effects and costs. Arbor’s terms provide a full refund when its clinician does not approve treatment.

Sources: [10] [12] [11] [8] [2]

The starting prices are documented; the full purchase needs confirmation

Current pages agree: Steady, the compounded injectable semaglutide program, starts at $99 per month, and Accelerate, the compounded injectable tirzepatide program, starts at $149. The product pages advertise medication, clinician care and check-ins in one price, with no increase as the dose rises. Broader homepage language adds consultations, clinical adjustments and dietitian-led nutrition support. These are monthly advertised amounts, not documented four-week prices. The consulted materials do not establish whether the minimum prices require a particular prepaid selection or promotion, and they do not give complete prepaid totals or the conditions of advertised buy-now-pay-later options.

Monthly billing is an option alongside discounted three-, six- and twelve-month plans paid in full at the start of each term; upfront payment is not mandatory for everyone. The billing consent describes ongoing oversight and consultations typically about every three months, with medication fulfillment and shipping only if prescribed. Arbor and accessible providers do not accept health insurance, Medicare, Medicaid or other government programs. HSA/FSA funds may be used for eligible services, but patients must confirm reimbursement eligibility. Finally, marketing promises of no price increases are qualified by terms reserving pricing or plan changes with at least 30 days’ notice where required by law.

Sources: [8] [11] [5] [9] [6] [10]

Follow the shipment and follow-up promises separately

The homepage advertises free FedEx Express shipping after approval and estimated delivery within 48 hours. That is distinct from the usual 24–48-hour clinical review, and neither interval guarantees a fixed total time from questionnaire to arrival. The FAQ describes automatic monthly refills on monthly subscriptions, each reviewed for progress, side effects and tolerance before authorization. Separately, the annual guarantee requires four medication shipments sent every three months. Public documentation does not clearly reconcile those schedules or specify universal laboratory requirements, laboratory costs, cold-chain procedures, damaged-delivery replacements or failed-delivery responsibilities.

Members use patient.mdintegrations.com for clinician messages, shipment tracking, prescription history, billing and labs. Arbor says the portal works in mobile and desktop browsers and supports two-factor authentication. It advertises 24/7 clinical access, while billing, shipping and account questions are handled during weekday business hours; this is not emergency care. No response-time guarantee should be inferred from access language. FDA advises not using an injectable GLP-1 product that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. FDA also reports measurement and administration errors with compounded medication, making clear prescriber or pharmacist instructions essential.

Sources: [9] [12] [10] [1]

Cancellation and the annual guarantee protect different things

Subscriptions renew automatically unless canceled. Arbor directs customers to message support before the renewal date; monthly plans have no minimum commitment, and access continues through the paid period. But cancellation is not a refund promise. Before a prescription is written, the terms deduct a $100 clinician consultation fee from a cancellation refund. Afterward, payment is generally nonrefundable and the order cannot be canceled. For prepaid terms, the first prescription makes the entire plan nonrefundable, including months not yet shipped. The terms also provide refunds for duplicate or incorrect charges and for orders not shipped because of an error by Arbor or the pharmacy. A renewal requested for cancellation before its date is avoided or refunded in full if charged before processing; later requests face the prescription and fee boundaries.

The twelve-month guarantee is substantially narrower than an unconditional money-back offer. It requires a new customer, uninterrupted enrollment, a standard-dose compounded plan, four quarterly shipments and compliance with the clinical program. Additional conditions include no outside weight-loss medication in the preceding twelve months and a claim within fourteen days after the annual period. The starting and target weights recorded at enrollment must not imply a target BMI below 18.5 or require a reduction exceeding 20% of starting weight. Approved claims return eligible subscription fees, excluding incidental costs and consultations outside membership; no prorated guarantee applies. Processing is within thirty days after verification approval, not guaranteed bank receipt. Separate treatment-unavailability provisions allow possible prorated refunds, processed within fourteen days when approved.

Sources: [6] [12] [10]

Nutrition and privacy deserve their own written answers

Arbor describes a supervised transition off medication after a patient reaches a goal, followed by personalized support from a registered dietitian. Elsewhere, it advertises nutrition plans, portions or meal plans and portal chat as completely optional—something to add when ready. That leaves the timing, duration, cost and included scope unresolved despite all-inclusive subscription language. The described transition is a service proposal, not evidence that results will persist after medication ends. NIH characterizes obesity as a chronic disease that may require long-term care. Our guide to clinical follow-up beyond renewal notices explains why continued assessment matters separately from subscription administration.

Privacy responsibilities are similarly divided across organizations. Arbor’s policy says it is not a HIPAA covered entity, may sometimes act as a business associate and leaves medical records and clinical decisions under the treating providers’ control. It states that it does not sell consumer health data, while allowing limited personal-data sharing for advertising where permitted by law. Those statements should not be collapsed into a claim that every interaction has identical protections or uses. Prospective members can ask which entity holds each category of information and which advertising controls apply. The English-language documentation also does not establish Spanish-language clinical care or interpretation.

Sources: [9] [7] [2]

Questions & answers

Does Arbor currently document access to branded GLP-1 medicines?

Not sufficiently to confirm a current branded offering. Its FAQ mentions FDA-approved medicines, and its footer allows approved or compounded prescribing, but the clearly advertised programs are compounded weekly injectable semaglutide and tirzepatide. Ask for the exact prescribed product, manufacturer or compounder, formulation and dispensing pharmacy before treating general approval language as a description of your order.

Sources: [12] [8] [9]

Must I pay for several months upfront to join Arbor?

The terms offer monthly billing as well as optional prepaid three-, six- and twelve-month plans. They do not establish which selections qualify for the minimum advertised prices. Confirm the amount collected today, renewal interval and total prepaid charge before checkout. A prepaid term also carries greater refund exposure because the first prescription makes the full term nonrefundable.

Sources: [10] [8]

What happens if the clinician declines my application?

Arbor’s terms promise a full refund if a clinician does not approve treatment. That differs from voluntarily canceling before a prescription, when the stated refund deducts a $100 consultation fee. Clinical review can also involve additional questions or a live consultation, so completing checkout does not guarantee approval or a prescription.

Sources: [10] [8]

Can I move an Arbor compounded prescription to my local pharmacy?

Arbor’s FAQ says its compounded prescriptions are written for a specific 503A compounding pharmacy and cannot transfer to retail pharmacies such as CVS or Walgreens. This is a material restriction on pharmacy choice. The public documentation does not name the dispensing pharmacies, so request that information and the pharmacy’s direct contact path before enrollment.

Sources: [12] [10]

Is a dietitian definitely included in the monthly price?

The documentation does not give one consistent answer. Homepage subscription language includes dietitian-led nutrition support, while another section calls the service optional and describes adding it when ready. Ask whether appointments and chat are included, when access begins, how long it lasts and whether support continues after medication or the subscription ends.

Sources: [9]

Whom do I contact about side effects, shipping or cancellation?

Arbor directs medical questions to the clinical team through patient.mdintegrations.com, with advertised 24/7 access. Billing, shipping and account matters receive weekday business-hours support; cancellation is requested by messaging support before renewal. Emergencies require 911 or an emergency department, not the portal. For an injectable delivery that arrives warm or insufficiently refrigerated, FDA advises not using it and contacting the provider or pharmacy.

Sources: [12] [1]

Our assessment

Arbor documents meaningful operational details: current starting prices, independent clinical review, a patient portal, prescription-dependent fulfillment and monthly or prepaid billing options. Those details support evaluating it as a telehealth access service, not treating it as a clinically validated outcome program. Its compounded products should remain distinct from approved-product trial evidence, and its annual guarantee should remain distinct from either a medical-results assurance or a routine cancellation refund. Before paying, the most useful written confirmations are the exact checkout charge and renewal schedule, named dispensing pharmacy, shipment frequency, dietitian entitlement and refund consequences for the selected plan. Arbor’s public documentation provides a starting point for those questions, but not complete answers.

Visit Arbor’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Arbor Review: What Its Compounded GLP-1 Program Documents—and What It Does Not

At a glance

01Start with the product, not the platform’s approval language

02Research supports narrower conclusions than a program promise

03The company, medical group and pharmacy have different jobs

04Enrollment is a clinical decision, not automatic approval

05The starting prices are documented; the full purchase needs confirmation

06Follow the shipment and follow-up promises separately

07Cancellation and the annual guarantee protect different things

08Nutrition and privacy deserve their own written answers